| Name | [3H]-Travoprost acid |
|---|---|
| Synonyms |
5-Heptenoic acid, 7-[3,5-dihydroxy-2-[(1E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-, (5E)-
(+)-FLUPROSTENOL (5E)-7-(3,5-Dihydroxy-2-{(1E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl)-5-heptenoic acid Travoprost Acid Fluprostenol |
| Description | (+)-Fluprostenol is a potent agonist of PTGER2. (+)-Fluprostenol decreases the expression of Oviductal glycoprotein 1 (OVGP1)[1]. |
|---|---|
| Related Catalog | |
| Target |
PTGER2[1] |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 608.0±55.0 °C at 760 mmHg |
| Molecular Formula | C23H29F3O6 |
| Molecular Weight | 458.468 |
| Flash Point | 321.5±31.5 °C |
| Exact Mass | 458.191620 |
| PSA | 107.22000 |
| LogP | 2.55 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.575 |
| RIDADR | UN 1992 6.1(3) / PGII |
|---|